Home / Docetaxel / United States
US ATC L01CD02 · updated 2 Nov 2026
Docetaxel shortage in United States
Is there a Docetaxel shortage in United States?
Yes. As of 2 Nov 2026, 2 Docetaxel products are reported short in United States, the first since 20 Feb 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Spain, Belgium, Switzerland, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08) discontinuation | Ingenus Pharmaceuticals LLC | 20 Feb 2026 | not given | Not stated |
| US | Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16) discontinuation | Ingenus Pharmaceuticals LLC | 20 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).